29th April, 2021
Amidst increasing cases of coronavirus and increasing demand, the central government is taking steps to increase the production of remedesivir injection, which is likely to go up to 3 lakh vials daily in the first week of May. Sources in the Ministry of Chemical and Fertilizers said that the government has already increased the production of remedesivir injection. The Ministry is monitoring the availability of Remadecivir injections in the market. By the first week of May, the production of Remadeswear will be increased to 3 lakh vials daily. Madesivir injection is an antiviral drug used in the treatment of coronavirus.
Sources in the ministry said that the government is making all efforts to make Remediswire available in the open market so that the current needs can be met. There has been a huge demand for Remedesivir injection due to the increase in Corona cases in the country. In the last few weeks, there have been many cases of hoarding and black marketing of Remedicivir injection.
Minister of State for Chemicals and Fertilizers (Manoj) Mansukh Mandavia on Wednesday chaired a meeting with public sector, private sector cooperative sector fertilizer companies to explore the possibility of production of oxygen in their plants. At a high level meeting, it was decided that about 50 metric tonnes of medical oxygen would be made available daily by fertilizer plants for patients with coronavirus. This step will increase the supply of medical-grade oxygen in the country's hospitals in the coming days.
Remadecivir exporters may get permission to sell in domestic market
The government may allow exporters to sell domestically to remove the shortage of injection remedesivir used in the treatment of corona infection. The exporters of this injection are seeking permission from the government for domestic sale of Remedesivir injection. The exporters have demanded this from the Drug Controller and the Foreign Trade Directorate.
In view of the shortage of Remedesvir in the country, the government had recently banned the export of this injection, but neither the exporters nor the country are benefiting from it. The production capacity of Remedesivir exporters is lying idle and they cannot even sell the injections available with them in the domestic market. Exporters can make these injections for the domestic market only if they get temporary permission from the Drug Control Department.
Ramesh Arora, MD of Remedesivir exporting company Quality Pharmaceuticals, said that with the temporary approval of exporters to sell in the domestic market, the additional production of Remedesivir daily could be 1.5 million vials and the price could be up to Rs 1,500 per wile. He told that his capacity alone is to make 50 thousand wiles daily.
Arora also said that the Foreign Trade Directorate has assured to listen to their demand. He has also sought permission to import raw materials for making injections. At present, only seven companies in the country are producing Remedesivir injection.